Standard Biotools (LAB) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.25% |
| Dec 31, 2025 | 11.69% |
| Sep 30, 2025 | 12.02% |
| Jun 30, 2025 | 29.21% |
| Mar 31, 2025 | 33.59% |
| Dec 31, 2024 | 48.05% |
| Sep 30, 2024 | 49.94% |
| Jun 30, 2024 | 59.67% |
| Mar 31, 2024 | 34.45% |
| Dec 31, 2023 | -11.26% |
| Sep 30, 2023 | 17.56% |
| Jun 30, 2023 | 29.41% |
| Mar 31, 2023 | 22.22% |
| Dec 31, 2022 | 7.23% |
| Sep 30, 2022 | 0.09% |
| Jun 30, 2022 | 13.74% |
| Mar 31, 2022 | -6.81% |
| Dec 31, 2021 | -3.41% |
| Sep 30, 2021 | -1.26% |
| Jun 30, 2021 | -2.35% |
| Mar 31, 2021 | 3.44% |
| Dec 31, 2020 | 19.02% |
| Sep 30, 2020 | 20.55% |
| Jun 30, 2020 | 13.15% |
| Mar 31, 2020 | -0.50% |
| Dec 31, 2019 | -6.78% |
| Sep 30, 2019 | -2.00% |
| Jun 30, 2019 | -9.77% |
| Mar 31, 2019 | -8.26% |
| Dec 31, 2018 | 22.03% |
| Sep 30, 2018 | 12.26% |
| Jun 30, 2018 | 4.07% |
| Mar 31, 2018 | -7.45% |
| Dec 31, 2017 | -0.20% |
| Sep 30, 2017 | -1.58% |
| Jun 30, 2017 | 32.07% |
| Mar 31, 2017 | 39.01% |
| Dec 31, 2016 | 20.93% |
| Sep 30, 2016 | 22.15% |
| Jun 30, 2016 | 28.80% |
| Mar 31, 2016 | -5.15% |
| Dec 31, 2015 | 38.45% |
| Sep 30, 2015 | 41.48% |
| Jun 30, 2015 | 24.09% |